learn RU58841
a potent but unapproved and potentially problematic topical anti-androgen
Search
forLearn
5 / 32 resultslearn Platelet-Derived Growth Factor Beta Polypeptide
learn Osteopontin
signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss
learn Overview
learn Estradiol
an estrogen promoting hair regrowth more commonly used in women
Research
5 / 1000+ results
research Safety Concerns Regarding 5α Reductase Inhibitors for the Treatment of Androgenetic Alopecia
5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.
research Safety Concerns When Using Novel Medications to Treat Alopecia
Consider benefits and risks of new alopecia treatments for safety.
research Safety Concerns of Paternal Drug Exposure on Fertility, Pregnancy, and Offspring: An Analysis Based on the FDA Adverse Event Reporting System
Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.
research BH19 'JAK in the Box?' Long-Term Safety Concerns with Oral Janus Kinase Inhibitors for Alopecia Areata
JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.
research Dermabrasion and Microdermabrasion: Rationale, Application, Safety Concerns, and Complications
Understanding and careful application of dermabrasion and microdermabrasion can minimize risks and improve patient outcomes.
Community Join
5 / 1000+ resultscommunity Safety of RU-58841: I talked to the Pharma Company that researched it, Human Clinical Trials, and Potential Reasons for Discontinuation
The safety and effectiveness of RU-58841 as a hair loss treatment, with some users reporting side effects like chest pains, while others had positive results. The original research on RU-58841 was likely stopped due to financial issues, not safety concerns.
community Prolactin’s role in antitumor activity of the immune system – a safety concern for HMI-115?
Hair loss discussion includes treatments Minoxidil, Finasteride, and RU58841. Prolactin's role in immune system's antitumor activity raises safety concerns for HMI-115.
community British man dies after falling ill at hair transplant clinic in Turkey
A British man's death at a Turkish hair transplant clinic raised safety concerns about such clinics. Users discussed risks of cheaper clinics and suggested alternatives like Thailand, Korea, and Colombia.
community Why isn't anyone using Way-316606? If it works then it grows a full head of hair back on most people
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.
community Research behind RU-58642? Has anyone heard of this?
RU-58642 is a powerful anti-androgen that was not developed further, possibly due to safety concerns or financial reasons. RU58841 is a topical alternative, but it is less effective than finasteride and dutasteride, and its long-term effects are not well-studied.